Live Breaking News & Updates on Association for research

Stay informed with the latest breaking news from Association for research on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Association for research and stay connected to the pulse of your community

Ocugen to Present on Modifier Gene Therapy Platform at

MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,...

Nieraj-jain , Arun-upadhyay , Joses-pulido , Murthy-chavali , Shankar-musunuri , Borooah-shyamanga , Benjamin-bakall , Arunk-upadhyay , Nalin-mehta , Sahar-matloob , Paul-yang

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

MALVERN, Pa., April 26, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the...

Shankar-musunuri , Murthy-chavali , Benjamin-bakall , Borooah-shyamanga , Arunk-upadhyay , Paul-yang , Nalin-mehta , Sahar-matloob , Arun-upadhyay , Nieraj-jain , Joses-pulido

UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

MALVERN, Pa., April 26, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the...

Murthy-chavali , Benjamin-bakall , Arun-upadhyay , Joses-pulido , Borooah-shyamanga , Arunk-upadhyay , Sahar-matloob , Shankar-musunuri , Paul-yang , Nieraj-jain , Nalin-mehta

eyeDNA Therapeutics to Present 2-year Follow-up Phase I/II Data on its Investigational Gene Therapy HORA-PDE6b for Retinitis Pigmentosa at the ARVO 2024 Annual Meeting

eyeDNA Therapeutics to Present 2-year Follow-up Phase I/II Data on its Investigational Gene Therapy HORA-PDE6b for Retinitis Pigmentosa at the ARVO 2024 Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France , South-korea , Paris , France-general- , United-states , Japan , China , Clerval , Franche-comtér , Sylvie-berrebi , Jean-baptiste-ducloyer , Leila-adlam

Opthea : to Present at the OIS Retina Innovation Summit at ARVO - Form 6-K

Opthea to Present at the OIS Retina Innovation Summit at ARVO

Melbourne, Australia and Princeton, NJ, April 25, 2024 -- Opthea Limited , a clinical-stage biopharmaceutical...

Washington , United-states , Australia , Seattle , Melbourne , Victoria , Fred-guerard , Frederic-guerard , Silvana-guerci-lena , Linkedin , Association-for-research , Lifesci-advisors

Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension

Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Taiwan , New-york , United-states , Formosa , Denise-pensyl , John-gandolfo , Eric-ribner , Norbert-lowe , Michael-rowe , Lifesci-advisors , University-of-new-york-school-optometry , Exchange-commission

Opthea to Present at the OIS Retina Innovation Summit at ARVO

Opthea to Present at the OIS Retina Innovation Summit at ARVO
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Washington , United-states , Melbourne , Victoria , Australia , Seattle , Frederic-guerard , Silvana-guerci-lena , Association-for-research , Linkedin , Lifesci-advisors , Opthea-limited

AAVantgarde announces updated NHP data from its Stargardt disease program in a poster presentation at the ARVO 2024 annual meeting

MILAN, Italy, April 24, 2024 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two…

Milan , Lombardia , Italy , Aavantgarde-bio , Association-for-research , Adeno-associated-viral , Ophthalmology-annual-meeting , News , Ggregator , Reaking-news , Uration , Edia

Sales of Roche's juggernaut Vabysmo rout the analyst consensus

Sales of Roche's juggernaut Vabysmo rout the analyst consensus
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Swiss , Teresa-graham , Roche-vabysmo , Thomas-schinecker , Association-for-research ,

PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024

DAEJEON, South Korea, April 23, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company

South-san-francisco , California , United-states , South-korea , Daejeon , Taejon-gwangyoksi , Thailand , Venice-chiueh , Wincal-biopharm-wincalbio , Taeweon-lee , Seattle-convention-center , Pharmabcine-inc